Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systematic review with meta-analysis: the efficacy and safety of tenofovir to prevent mother-to-child transmission of hepatitis B virus
Myung Han Hyun, Young‐Sun Lee, Ji Hoon Kim, et al.
Alimentary Pharmacology & Therapeutics (2017) Vol. 45, Iss. 12, pp. 1493-1505
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

The changing epidemiology of liver diseases in the Asia–Pacific region
Martin C. S. Wong, Jason L. Huang, Jacob George, et al.
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 16, Iss. 1, pp. 57-73
Closed Access | Times Cited: 280
KASL clinical practice guidelines for management of chronic hepatitis B

Clinical and Molecular Hepatology (2019) Vol. 25, Iss. 2, pp. 93-159
Open Access | Times Cited: 191
Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis
Anna Funk, Ying Lu, Kyoko Yoshida, et al.
The Lancet Infectious Diseases (2020) Vol. 21, Iss. 1, pp. 70-84
Open Access | Times Cited: 154
Real-world implementation of a multilevel interventions program to prevent mother-to-child transmission of HBV in China
Xueru Yin, Wei Wang, Hui Chen, et al.
Nature Medicine (2024) Vol. 30, Iss. 2, pp. 455-462
Open Access | Times Cited: 20
Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop
Hyung Joon Yim, Ji Hoon Kim, Jun Yong Park, et al.
Clinical and Molecular Hepatology (2020) Vol. 26, Iss. 4, pp. 411-429
Open Access | Times Cited: 85
S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion – (AWMF-Register-Nr. 021-11)
Markus Cornberg, Lisa Sandmann, Ulrike Protzer, et al.
Zeitschrift für Gastroenterologie (2021) Vol. 59, Iss. 07, pp. 691-776
Open Access | Times Cited: 73
The impact of the timely birth dose vaccine on the global elimination of hepatitis B
Margaret J. de Villiers, Shevanthi Nayagam, Timothy B. Hallett
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 65
Prevention of vertical transmission of hepatitis B virus infection
Piero Veronese, Icilio Dodi, Susanna Esposito, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 26, pp. 4182-4193
Open Access | Times Cited: 64
Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Preventing Vertical Transmission in Chronic Hepatitis B Mothers: A Systematic Review and Meta-Analysis
Calvin Q. Pan, Lin Zhu, Andy Yu, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 4, pp. 953-964
Closed Access | Times Cited: 12
How far are we from viral hepatitis elimination service coverage targets?
Yvan Hutin, Marc Bulterys, Gottfried Hirnschall
Journal of the International AIDS Society (2018) Vol. 21, Iss. S2
Open Access | Times Cited: 65
The epidemiology of hepatitis B virus infection in Korea
Sun Young Yim, Ji Hoon Kim
The Korean Journal of Internal Medicine (2019) Vol. 34, Iss. 5, pp. 945-953
Open Access | Times Cited: 59
Screening for Hepatitis B Virus Infection in Pregnant Women
Douglas K Owens, Karina W. Davidson, Alex H. Krist, et al.
JAMA (2019) Vol. 322, Iss. 4, pp. 349-349
Open Access | Times Cited: 55
Hepatitis B – Vertical transmission and the prevention of mother-to-child transmission
Ka Wang Cheung, Terence T. Lao
Best Practice & Research Clinical Obstetrics & Gynaecology (2020) Vol. 68, pp. 78-88
Closed Access | Times Cited: 48
Accelerating progress towards the elimination of mother‐to‐child transmission of HIV: a narrative review
H. Benjamin, Dorothy Mbori‐Ngacha, Shaffiq Essajee, et al.
Journal of the International AIDS Society (2020) Vol. 23, Iss. 8
Open Access | Times Cited: 40
Incidence of mother‐to‐child transmission of hepatitis B in relation to maternal peripartum antiviral prophylaxis: A systematic review and meta‐analysis
Naijuan Yao, Shan Fu, Yuchao Wu, et al.
Acta Obstetricia Et Gynecologica Scandinavica (2022) Vol. 101, Iss. 11, pp. 1197-1206
Open Access | Times Cited: 20
Tenofovir and Hepatitis B Virus Transmission During Pregnancy
Calvin Q. Pan, Erhei Dai, Zhongfu Mo, et al.
JAMA (2024)
Closed Access | Times Cited: 4
Management of hepatitis B virus infection, updated Swedish guidelines
Johan Westin, Soo Aleman, Maria Castedal, et al.
Infectious Diseases (2019) Vol. 52, Iss. 1, pp. 1-22
Open Access | Times Cited: 32
Prevention of perinatal hepatitis B virus transmission
Ka Wang Cheung, Mimi Tin Yan Seto, Terence T. Lao
Archives of Gynecology and Obstetrics (2019) Vol. 300, Iss. 2, pp. 251-259
Closed Access | Times Cited: 31
Mother‐to‐child transmission of hepatitis B: What more needs to be done to eliminate it around the world?
Shevanthi Nayagam, Yusuke Shimakawa, Maud Lemoine
Journal of Viral Hepatitis (2019) Vol. 27, Iss. 4, pp. 342-349
Open Access | Times Cited: 30
Hepatitis B: Who and when to treat?
Jiannis Vlachogiannakos, George Papatheodoridis
Liver International (2018) Vol. 38, Iss. S1, pp. 71-78
Open Access | Times Cited: 30
Impact of Hepatitis B Virus Genetic Variation, Integration, and Lymphotropism in Antiviral Treatment and Oncogenesis
Keith C.K. Lau, Kelly W. Burak, Carla S. Coffin
Microorganisms (2020) Vol. 8, Iss. 10, pp. 1470-1470
Open Access | Times Cited: 24
Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa
Jolynne Mokaya, Edward Burn, Cynthia Tamandjou, et al.
BMC Public Health (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 23
Progress towards elimination of mother-to-child transmission of hepatitis B virus infection in China: a modelling analysis
Hui Zheng, Shevanthi Nayagam, Polin Chan, et al.
Bulletin of the World Health Organization (2020) Vol. 99, Iss. 1, pp. 10-18
Open Access | Times Cited: 17
Downregulation of the long non-coding RNA MALAT1 in tenofovir-treated pregnant women with hepatitis B virus infection promotes immune recovery of natural killer cells via the has-miR-155-5p/HIF-1α axis
Fanfan Guo, Yufei Yuan, Ziyi Chen, et al.
International Immunopharmacology (2022) Vol. 107, pp. 108701-108701
Open Access | Times Cited: 11
Tenofovir disoproxil fumarate therapy to prevent hepatitis B virus vertical transmission—A review of maternal and infant outcomes
Golasa Samadi Kochaksaraei, Abdel Aziz Shaheen, Cynthia H. Seow, et al.
Liver International (2022) Vol. 42, Iss. 8, pp. 1712-1730
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top